| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Rongen Roelof serves as a Chief Executive Officer at MTNB. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $4.8M at current prices.
The biggest single holding is MTNB (~$4.8M) as Chief Executive Officer. Net of sales, the recent Form 4 record there shows accumulation of 5,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2017 | MTNB Matinas Biopharma Holdings, Inc. | Chief Executive Officer | Buy | 5,000 | $1.36 | $6,800.00 | +0.1% |